Global  

VA says it’ll stop almost all use of unproven drug on vets

Seattle Times Thursday, 28 May 2020
WASHINGTON (AP) — Veterans Affairs Secretary Robert Wilkie said Thursday that his department has all but stopped use of an unproven malaria drug on veterans with COVID-19. At a House hearing, he defended initial use of hydroxychloroquine on coronavirus patients as justified “to give them hope,” given few treatment options at the time. But Wilkie […]
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

Return To Sender? Millions Of Hydroxychloroquine Pills Locked In Limbo [Video]

Return To Sender? Millions Of Hydroxychloroquine Pills Locked In Limbo

President Donald Trump once touted hydroxychloroquine as “game changers” in the fight against the novel coronavirus COVID-19. Now, millions of doses of the drug are in limbo after the Food and Drug..

Credit: Wochit Business     Duration: 00:35Published
WHO warns against use of hydroxycholoroqine to treat Covid-19 [Video]

WHO warns against use of hydroxycholoroqine to treat Covid-19

A World Health Organisation official has warned against the use of the anti-malarial drug hydroxychloroquine to treat Covid-19, following President Donald Trump's claim on May 19 that he was taking the..

Credit: PA - Press Association STUDIO     Duration: 01:08Published
Trump defends hydroxychloroquine use as others caution against it [Video]

Trump defends hydroxychloroquine use as others caution against it

U.S. President Donald Trump on Tuesday defended his use of a prescription malaria drug to try to ward off the novel coronavirus despite medical warnings, saying it was up to individuals to make their..

Credit: Reuters Studio     Duration: 02:49Published

Related news from verified sources

VA says it won’t stop use of unproven drug on vets for now

WASHINGTON (AP) — Facing growing criticism, the Department of Veterans Affairs said Friday that it will not halt use of an unproven malaria drug on veterans...
SeattlePI.com Also reported by •Seattle Times

Tweets about this